Banque de Luxembourg Investments (BLI)’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.2M Hold
247,000
0.39% 68
2025
Q4
$13.4M Hold
247,000
0.39% 69
2025
Q3
$10.9M Hold
247,000
0.32% 89
2025
Q2
$11.4M Hold
247,000
0.33% 86
2025
Q1
$14.8M Hold
247,000
0.45% 61
2024
Q4
$13.8M Buy
+247,000
New +$13.8M 0.38% 73

Other funds holding BMY

Banque de Luxembourg Investments (BLI)'s BMY Position: Q1 2026 in Review

Banque de Luxembourg Investments (BLI) held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 247,000 shares worth $13.2M. The position accounts for 0.39% of the portfolio, ranked #68.

Banque de Luxembourg Investments (BLI) first reported a position in BMY in Q4 2024 and has held it in 6 quarters since. The position peaked at $14.8M in Q1 2025. 2,526 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Banque de Luxembourg Investments (BLI) held 247,000 shares of Bristol-Myers Squibb worth $13.2M as of Q1 2026.
  • Banque de Luxembourg Investments (BLI) left its Bristol-Myers Squibb share count unchanged in Q1 2026.
  • Bristol-Myers Squibb made up 0.39% of Banque de Luxembourg Investments (BLI)'s portfolio in Q1 2026, its #68 holding.
  • Banque de Luxembourg Investments (BLI) first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 6 quarters since.
  • Banque de Luxembourg Investments (BLI)'s Bristol-Myers Squibb position peaked at $14.8M in Q1 2025.
  • 2,526 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Banque de Luxembourg Investments (BLI)'s 13F filing for Q1 2026, filed 15 May 2026.